60 Degrees Pharmaceuticals Inc (SXTP)

Currency in USD
1.960
-0.260(-11.71%)
Closed·
1.920-0.040(-2.04%)
·
SXTP is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.8602.400
52 wk Range
0.4508.620
Key Statistics
Prev. Close
2.22
Open
2.19
Day's Range
1.86-2.4
52 wk Range
0.45-8.62
Volume
1.55M
Average Vol. (3m)
4.6M
1-Year Change
-43.1884%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SXTP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria preventative treatment. The company also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal pneumonias, and candidiasis disease; and Celgosivir for Zika, respiratory viruses, and dengue. It also has patent license agreement with Tufts Medical Center to jointly advance the development and commercialization of tafenoquine for the treatment and prevention of babesiosis. The company was founded in 2010 and is headquartered in Washington, District Of Columbia.

Employees
3

Compare SXTP to Peers and Sector

Metrics to compare
SXTP
Peers
Sector
Relationship
P/E Ratio
0.0x−4.9x−0.5x
PEG Ratio
0.00−0.130.00
Price / Book
0.0x1.6x2.6x
Price / LTM Sales
0.0x4.7x3.2x
Upside (Analyst Target)
0.0%110.1%47.6%
Fair Value Upside
Unlock9.1%6.1%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
H.C. Wainwright
Buy6.00+206.12%-New CoverageNov 14, 2025
Ascendiant Capital
Buy7.00+257.14%8.50MaintainJun 02, 2025

Earnings

Latest Release
Mar 30, 2026
EPS / Forecast
-1.91 / -0.08
Revenue / Forecast
300K / --
EPS Revisions
Last 90 days

SXTP Income Statement

People Also Watch

1.28
TMDE
-3.76%
2.6500
RENX
-7.34%
0.6250
RAYA
+0.10%
2.000
TURB
-2.44%

FAQ

What Is the 60 Degrees Pharmaceuticals (SXTP) Stock Price Today?

The 60 Degrees Pharmaceuticals stock price today is 1.960 USD.

What Stock Exchange Does 60 Degrees Pharmaceuticals Trade On?

60 Degrees Pharmaceuticals is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for 60 Degrees Pharmaceuticals?

The stock symbol for 60 Degrees Pharmaceuticals is "SXTP."

What Is the 60 Degrees Pharmaceuticals Market Cap?

As of today, 60 Degrees Pharmaceuticals market cap is 29.520M USD.

What Is 60 Degrees Pharmaceuticals's Earnings Per Share (TTM)?

The 60 Degrees Pharmaceuticals EPS (TTM) is -11.737.

When Is the Next 60 Degrees Pharmaceuticals Earnings Date?

60 Degrees Pharmaceuticals will release its next earnings report on May 14, 2026.

From a Technical Analysis Perspective, Is SXTP a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has 60 Degrees Pharmaceuticals Stock Split?

60 Degrees Pharmaceuticals has split 0 times.

How Many Employees Does 60 Degrees Pharmaceuticals Have?

60 Degrees Pharmaceuticals has 3 employees.

What is the current trading status of 60 Degrees Pharmaceuticals (SXTP)?

As of Apr 15, 2026, 60 Degrees Pharmaceuticals (SXTP) is trading at a price of 1.960 USD, with a previous close of 2.220 USD. The stock has fluctuated within a day range of 1.860 USD to 2.400 USD, while its 52-week range spans from 0.450 USD to 8.620 USD.

What Is the SXTP Premarket Price?

SXTP's last pre-market stock price is 2.260 USD. The pre-market share volume is 460,330.000, and the stock has decreased by 0.040, or 1.800%.

What Is the SXTP After Hours Price?

SXTP's last after hours stock price is 1.920 USD, the stock has decreased by -0.040, or -2.040%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.